作者: J. David Peske , Amber B. Woods , Victor H. Engelhard
DOI: 10.1016/BS.ACR.2015.05.001
关键词:
摘要: CD8 T-cells are a critical brake on the initial development of tumors. In established tumors, presence is correlated with positive patient prognosis, although immunosuppressive mechanisms limit their effectiveness and they rarely curative without manipulation. Cancer immunotherapies aim to shift balance back dominant antitumor immunity through antibody blockade signaling pathways, vaccination, adoptive transfer activated or engineered T-cells. These approaches have yielded striking responses in small subsets patients solid most notably those melanoma. Importantly, subset who respond vaccination immunosuppression therapies present tumor prior initiating therapy. While current cell therapy can be dramatically effective, require infusion extremely large numbers T-cells, but number that actually infiltrates very small. Thus, poor representation tumors fundamental hurdle successful immunotherapy, over above well-established barrier immunosuppression. this review, we discuss factors determine whether immune cells focus cytotoxic We emphasize critically important role tumor-associated vasculature as gateway enables active infiltration both effector naive exert activity. also strategies enhance function extend broader set cancer patients.